Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Dorrit Larsen has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12729555

METHOD OF ADMINISTRATION OF 4-((1R,3S)-6-CHLORO-3-PHENYL-INDAN-1-YL)-1,2,2-TRIMETHYL-PIPERAZINE AND THE SALTS THEREOF IN THE TREATMENT OF SCHIZOPHRENIA

IPC classification:
A61K 31/496, A61P 25/18
Applicant:
H. Lundbeck A/S
Agent:
Multiple attorneys, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED
EP12740520

POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR

IPC classification:
A61K 31/4355, A61K 31/436, A61K 31/44, A61K 31/505, A61P 25/00, C07D 213/26, C07D 213/30, C07D 213/40, C07D 213/61, C07D 213/64, C07D 213/71, C07D 213/74, C07D 213/78, C07D 405/12, C07D 491/04
Applicant:
H. Lundbeck A/S
Agent:
Multiple attorneys, H. Lundbeck A/S
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature